Literature DB >> 10695012

Helicobacter pylori and gastroesophageal reflux disease.

D C Metz1, J A Kroser.   

Abstract

The nature of the relationship between Helicobacter pylori (Hp) infection and gastroesophageal reflux disease (GERD) remains unclear. This article reviews the current body of knowledge regarding the association between these two common entities. The authors examine the potential interactions of Hp and GERD from epidemiologic and pathophysiologic viewpoints and summarize and critique the prevalence and eradication studies that have been performed to date. Special consideration is given to the possible effects that long-term use of proton pump inhibitors may have on Hp gastritis.

Entities:  

Mesh:

Year:  1999        PMID: 10695012     DOI: 10.1016/s0889-8553(05)70100-x

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  5 in total

1.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 3.  Gastroesophageal reflux disease: From pathophysiology to treatment.

Authors:  Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.

Authors:  H H Xia; N Phung; E Altiparmak; A Berry; M Matheson; N J Talley
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

5.  Prevalence of gastroesophageal reflux disease and its association with Helicobacter pylori infection in chronic renal failure patients and in renal transplant recipients.

Authors:  Ibraheim S Abdulrahman; Abdulaziz A Al-Quorain
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.